Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster
ABSTRACT: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sublineage B.1.617.2 or Delta, a variant that began circulating in India and is becoming dominant in the USA, has been responsible for significant morbidity and mortality. In May 2021, the Delta variant was upgraded to a variant...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2022
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/52bd5f1be98c4a7b8d31ec631ce2ec32 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|